ハイコンテンツスクリーニング市場 – 2030年までの世界予測

Report Overview

The global high content screening market is anticipated to reach USD 2.19 billion in 2030 from USD 1.52 billion in 2025, with a significant CAGR of 7.5%.

世界のハイコンテンツスクリーニング市場は、2025年の15億2,000万米ドルから2030年には21億9,000万米ドルに達し、7.5%という大幅なCAGRで成長すると予想されています。

The market is growing at a significant CAGR owing to the innovations in high-resolution imaging, automation, and artificial intelligence (AI)-powered data analysis, which have significantly enhanced the efficiency and accuracy of HCS workflows. Advanced instruments equipped with high-speed fluorescence microscopy, confocal imaging, and real-time live-cell analysis enable deeper cellular insights, making them essential for drug discovery, toxicity screening, and disease research.

高解像度イメージング、自動化、人工知能 (AI) を活用したデータ分析の革新により、市場は大幅な CAGR で成長しており、HCS ワークフローの効率と精度が大幅に向上しています。高速蛍光顕微鏡、共焦点イメージング、リアルタイムの生細胞分析を備えた高度な機器により、より深い細胞洞察が可能になり、創薬、毒性スクリーニング、疾患研究に不可欠なものとなっています。

“Instruments dominated the products & service segment”

Based on product & service, the high content screening market is divided into instruments, consumables & accessories, software, and services. The instrument segment is further divided into high content imaging platforms, cell detection and analysis systems, and cell imaging systems. The rising demand for high-throughput screening and multiplexed assays in pharmaceutical and biotechnology research has accelerated the adoption of next-generation HCS systems. As research institutions and commercial laboratories seek to improve productivity and efficiency, the demand for cutting-edge HCS instruments is expected to drive significant market growth.

“Drug discovery & development application segment is anticipated to grow at a great pace”

The application segment is divided into drug discovery & development applications, toxicology, and basic research. The drug discovery & development application segment is further divided into primary screening and secondary screening, target identification and validation, compound profiling, and other drug discovery & development applications. The drug discovery & development dominated the market owing to the integration of artificial intelligence and automation in drug discovery workflows further enhances the efficiency of HCS, reducing time and costs associated with preclinical research. Furthermore, regulatory bodies emphasize early toxicity assessment, making HCS a preferred choice for evaluating drug safety before clinical trials. These factors collectively contribute to the dominant market share of drug discovery and development applications in the HCS market.

“Pharmaceutical & Biotechnology Companies dominated the segment”

Based on the end users, the market is segmented into pharmaceutical & biotechnology companies, academic & government institutes, and CROs & CDMOs. Pharmaceutical & biotechnology companies dominated the segment in 2024. The high share of pharmaceutical and biotechnology companies in the high content screening (HCS) market is primarily driven by their extensive use of HCS technologies in drug discovery and development. These companies rely on HCS for high-throughput screening, lead optimization, and toxicity assessment to accelerate the drug development process while ensuring safety and efficacy.

“North America: the largest share of the high content screening market”

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the high content screening market in 2024 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the presence of leading academic & research institutions, and significant investment in biotechnology. The country’s focus on innovative medical research, personalized healthcare, and precision medicine further boosts its leadership in the market. European high content screening market is experiencing steady growth, supported by increasing research and development activities, especially in countries like Germany, the UK, and France.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the high content screening market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Tire 1- 55%, Tire 2-25%, Tire 3- 20%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

The prominent players operating in the high content screening market are Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Corning Incorporated (US), Bio-Rad Laboratories Inc (US), Tecan Trading AG (Switzerland), Evident (Japan), Sysmex Corporation (Japan), Yokogawa Electric Corporation (Japan), Nikon Corporation (Japan),  Sartorius AG (Germany), Promega Corporation (US), Creative Biolabs (US), Enzo Life Sciences (US), Stratedigm Inc. (US), Akoya Biosciences, Inc. (US), Sphere Fluidics (UK), Creative Biostructure (US), Creative Bioarray (US), Cell Signalling Technology (US), Standard Biotools (US), Araceli Biosciences (US), and among others.

Research Coverage:

High content screening market report is segmented based on products & services (instruments (high content imaging platforms, cell detection and analysis systems, and cell imaging systems), consumables & accessories (reagents & assay kits, microplates, and other consumables accessories), software, and services. Applications (drug discovery & development applications (primary screening and secondary screening, target identification and validation, compound profiling, and other drug discovery & development applications), toxicology, and basic research, end users (pharmaceutical & biotechnology companies, academic & government institutes, and CROs & CDMOs). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the high content screening market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the high content screening market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the high content screening and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Advancements in Imaging Technologies, Increased R&D projects, Adoption of High Throughput Screening, implementing organoid models in HCS), restraints (High Equipment and Reagents Costs, Complexity of Data Analysis), opportunities (Integration of AI and ML, Expansion into new applications) and Challenges (Lack of Standardized Protocol) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on upcoming technologies in high content screening, research and development activities, and new product launches in the high content screening market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Danaher Corporation (US), Revvity, Inc. (US), BD (US), Carl Zeiss AG (Germany), Merck KGaA (Germany), and Thermo Fisher Scientific, Inc. (US), among others.

Table of Contents

1              INTRODUCTION

1.1           OBJECTIVES OF THE STUDY

1.2           MARKET DEFINITION

1.2.1        INCLUSIONS AND EXCLUSIONS

1.3           MARKET SCOPE

1.3.1        MARKETS COVERED

1.3.2        YEARS CONSIDERED FOR THE STUDY

1.4           CURRENCY USED FOR THE STUDY

1.5           LIMITATIONS

1.6           MARKET STAKEHOLDERS

1.7          SUMMARY OF CHANGES

1.7.1       IMPACT OF AI/GENERATIVE AI

2              RESEARCH METHODOLOGY

2.1           RESEARCH DATA

2.1.1        SECONDARY DATA

2.1.2        PRIMARY DATA

2.2          MARKET SIZE ESTIMATION

2.2.1       INSIGHTS FROM PRIMARY

2.2.2       SEGMENT ASSESSMENT METHODOLOGY

2.3           MARKET GROWTH RATE PROJECTIONS

2.4           DATA TRIANGULATION

2.5           RESEARCH ASSUMPTIONS

2.6           LIMITATIONS

2.7           RISK ASSESSMENT

3              EXECUTIVE SUMMARY

4              PREMIUM INSIGHTS

5              MARKET OVERVIEW

5.1          INTRODUCTION

5.2          MARKET DYNAMICS

5.2.1       DRIVERS

5.2.2       RESTRAINTS

5.2.3       OPPORTUNITIES

5.2.4       CHALLENGES

5.3          TRENDS/DISRUPTIONS IMPACTING CUSTOMERS BUSINESS

5.4          PRICING ANALYSIS

5.4.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT

5.4.2        AVERAGE SELLING PRICE TREND, BY REGION

5.5          SUPPLY CHAIN ANALYSIS

5.6          VALUE CHAIN ANALYSIS

5.7          ECOSYSTEM ANALYSIS

5.8          IMPACT OF AI/GEN AI

5.9          TECHNOLOGY ANALYSIS

5.9.1       KEY TECHNOLOGIES

5.9.2       COMPLEMENTARY TECHNOLOGIES

5.9.3       ADJACENT TECHNOLOGIES

5.10        PATENT ANALYSIS

5.11         KEY CONFERENCES & EVENTS 2025-2026

5.12        REGULATORY LANDSCAPE

5.12.1     REGULATORY SCENARIO

5.12.2     REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS

5.13        PORTER’S FIVE FORCES ANALYSIS

5.13.1    THREAT OF NEW ENTRANTS

5.13.2    THREAT OF SUBSTITUTE

5.13.3    BARGAINING POWER OF SUPPLIERS

5.13.4    BARGAINING POWER OF BUYERS

5.13.5    INTENSITY OF COMPETITION RIVALRY

5.14        KEY STAKEHOLDERS AND BUYING CRITERIA

5.14.1    KEY STAKEHOLDERS IN THE BUYING PROCESS

5.14.2    BUYING CRITERIA FOR END USERS

5.15        INVESTMENT AND FUNDING SCENARIO

6              HIGH CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)

6.1           INTRODUCTION

6.2           INSTRUMENTS

6.2.1        CELL IMAGING SYSTEMS

6.2.2        CELL DETECTION AND ANALYSIS SYSTEMS

6.2.3        HIGH CONTENT IMAGING PLATFORMS

6.3           CONSUMABLES & ACCESSORIES

6.3.1        REAGENTS & ASSAY KITS

6.3.2        MICROPLATES

6.3.3        OTHER CONSUMABLES & ACCESSORIES

6.4           SOFTWARE

6.5           SERVICES

Note 1: Other consumables & accessories segment is inclusive of cell culture accessories, microscopy accessories, and plate sealers.

Note 2: The above product & service segmentation is subject to change during research.

7              HIGH CONTENT SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)

7.1           INTRODUCTION

7.2           DRUG DISCOVERY AND DEVELOPMENT

7.2.1        TARGET IDENTIFICATION AND VALIDATION

7.2.2        PRIMARY SCREENING AND SECONDARY SCREENING

7.2.3        COMPOUND PROFILING

7.2.4        OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS (IF ANY)

7.2           TOXICOLOGY

7.3           BASIC RESEARCH

Note 3: Basic research application segment is inclusive of cancer cell line screening, epigenetics, gene expression analysis, and stem cell research.

8              HIGH CONTENT SCREENING MARKET, BY END USER, 2022-2029 (USD MILLION)

8.1           INTRODUCTION

8.2           PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

8.3           ACADEMIC AND GOVERNMENT INSTITUTES

8.4           CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS

9              HIGH CONTENT SCREENING MARKET, BY REGION, 2022-2029 (USD MILLION)

9.1           INTRODUCTION

9.2           NORTH AMERICA

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA

9.2.2        US

9.2.3        CANADA

9.3           EUROPE

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE

9.3.2        GERMANY

9.3.3        UK

9.3.4        FRANCE

9.3.5        ITALY

9.3.6        SPAIN

9.3.7        REST OF EUROPE

9.4           ASIA PACIFIC

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

9.4.2        JAPAN

9.4.3        CHINA

9.4.4        INDIA

9.4.5        SOUTH KOREA

9.4.6        AUSTRALIA

9.4.7        REST OF ASIA PACIFIC

9.5           LATIN AMERICA

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA

9.5.2        BRAZIL

9.5.3        REST OF LATIN AMERICA

9.6           MIDDLE EAST

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST

9.6.2        GCC COUNTRIES

9.6.2.1       UNITED ARAB EMIRATES (UAE)

9.6.2.2       KINGDOM OF SAUDI ARABIA (KSA)

9.6.2.3       REST OF GCC COUNTRIES

12.6.3       REST OF MIDDLE EAST

9.7           AFRICA

9.7.1      MACROECONOMIC OUTLOOK FOR AFRICA

10            COMPETITIVE LANDSCAPE

10.1        INTRODUCTION

10.2        KEY PLAYERS STRATEGIES/ RIGHT TO WIN

10.3        REVENUE SHARE ANALYSIS (TOP 4-5 PLAYERS)

10.4        MARKET SHARE ANALYSIS (TOP 4-5 PLAYERS)

10.5        COMPANY EVALUATION MATRIX: KEY PLAYERS

10.5.1    STARS

10.5.2    EMERGING LEADERS

10.5.3    PERVASIVE PLAYERS

10.5.4    PARTICIPANTS

10.5.5     COMPANY FOOTPRINT: KEY PLAYERS

10.5.5.1 COMPANY FOOTPRINT

10.5.5.2 PRODUCT FOOTPRINT

10.5.5.3 SERVICE FOOTPRINT

10.5.5.4 APPLICATION FOOTPRINT

10.5.5.5 REGION FOOTPRINT

10.6        COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023

10.6.1    PROGRESSIVE COMPANIES

10.6.2    RESPONSIVE COMPANIES

10.6.3    DYNAMIC COMPANIES

10.6.4    STARTING BLOCKS

10.6.5     COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023

10.6.5.1 DETAILED LIST OF KEY STARTUPS/ SMES

10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/ SMES

10.7        COMPETITIVE SCENARIO

10.7.1    DEALS

10.7.2    OTHER DEVELOPMENTS

10.8        BRAND/ PRODUCT COMPARATIVE ANALYSIS

10.9        VENDOR VALUATION AND FINANCIAL METRICS OF THE RESIDUAL DNA TESTING MARKET

11            COMPANY PROFILES

11.1         KEY PLAYERS

11.1.1     DANAHER CORPORATION

11.1.2     REVVITY

11.1.3     BD

11.1.4     THERMO FISHER SCIENTIFIC INC.

11.1.5     AGILENT TECHNOLOGIES

11.1.6     MERCK KGAA

11.1.7     BIO-RAD LABORATORIES, INC.

11.1.8     NIKON INSTRUMENTS INC.

11.1.9                 CARL ZEISS AG

11.1.10                 SARTORIUS AG

11.1.11   YOKOGAWA ELECTRIC CORPORATION

11.1.12   TECAN TRADING AG

11.1.13   CORNING INCORPORATED

11.1.14   CHARLES RIVER LABORATORIES

11.2         OTHER PLAYERS

11.2.1     EVIDENT

11.2.2     PROMEGA CORPORATION

11.2.3     CREATIVE BIOLABS

11.2.4     SYSMEX CORPORATION

11.2.5     ENZO LIFE SCIENCES

11.2.6     STRATEDIGM CORPORATION

11.2.7     AKOYA BIOSCIENCES

11.2.8     SPHERE FLUIDICS

11.2.9     CREATIVE BIOSTRUCTURE

11.2.10   CREATIVE BIOARRAY

11.2.11   CELL SIGNALLING TECHNOLOGY

11.2.12   STANDARD BIOTOOLS

11.2.13   ARACELI BIOSCIENCES

12            APPENDIX

12.1         DISCUSSION GUIDE

12.2         KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

12.3         INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE

12.4         AVAILABLE CUSTOMIZATIONS

12.5         RELATED REPORTS

12.6         AUTHOR DETAILS

LIST OF TABLES:

TABLE 1   IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

TABLE 2   HIGH-CONTENT SCREENING MARKET: RISK ANALYSIS

TABLE 3   AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY KEY PLAYER, 2022–2024

TABLE 4   AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY REGION, 2022–2024

TABLE 5   IMPORT DATA FOR HS CODE 901190, 2019–2023 (USD)

TABLE 6   EXPORT DATA FOR HS CODE 901190, 2019–2023 (USD)

TABLE 7   HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 8   HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 9   HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 10 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 11 EUROPE: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 12 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 13 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 14 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 15 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 16 HIGH-CONTENT IMAGING PLATFORMS MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 17 NORTH AMERICA: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 18 EUROPE: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 19 HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 20 LATIN AMERICA: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 21 MIDDLE EAST: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 22 GCC COUNTRIES: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 23 GCC COUNTRIES: HIGH-CONTENT IMAGING PLATFORMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 24 NORTH AMERICA: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 25 EUROPE: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 26 ASIA PACIFIC: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 27 LATIN AMERICA: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 28 MIDDLE EAST: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 29 GCC COUNTRIES: CELL IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 30 CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 31 NORTH AMERICA: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 32 EUROPE: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 33 ASIA PACIFIC: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 34 LATIN AMERICA: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 35 MIDDLE EAST: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 36 GCC COUNTRIES: CELL DETECTION & ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 37 HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 38 HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 39 NORTH AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 40 EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 41 ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 42 LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 43 MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 44 GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 45 REAGENTS & ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 46 NORTH AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 47 EUROPE: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 48 ASIA PACIFIC: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 49 LATIN AMERICA: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 50 MIDDLE EAST: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 51 GCC COUNTRIES: REAGENTS & ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 52 MICROPLATES MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 53 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 54 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 55 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 56 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 57 MIDDLE EAST: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 58 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 59 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 60 NORTH AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 61 EUROPE: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 62 ASIA PACIFIC: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 63 LATIN AMERICA: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 64 MIDDLE EAST: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 65 GCC COUNTRIES: OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 66 HIGH-CONTENT SCREENING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 67 NORTH AMERICA: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 68 EUROPE: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 69 ASIA PACIFIC: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 70 LATIN AMERICA: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 71 MIDDLE EAST: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 72 GCC COUNTRIES: HIGH-CONTENT SCREENING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 73 HIGH-CONTENT SCREENING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 74 NORTH AMERICA: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 75 EUROPE: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 76 ASIA PACIFIC: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 77 LATIN AMERICA: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 78 MIDDLE EAST: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 79 GCC COUNTRIES: HIGH-CONTENT SCREENING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 80 HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 81 HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 82 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 83 EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 84 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 85 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 86 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 87 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 88 HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 89 HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 90 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 91 EUROPE: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 92 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 93 LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 94 MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 95 GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR PRIMARY & SECONDARY SCREENING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 96 HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 97 NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 98 EUROPE: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 99 ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 100               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 101               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 102               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR TARGET IDENTIFICATION & VALIDATION APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 103               HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 104               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 105               EUROPE: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 106               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 107               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 108               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 109               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR COMPOUND PROFILING APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 110               HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 111               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 112               EUROPE: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 113               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 114               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 115               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 116               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 117               HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 118               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 119               EUROPE: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 120               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 121               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 122               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 123               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR TOXICOLOGY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 124               HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)

TABLE 125               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 126               EUROPE: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 127               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 128               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 129               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 130               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 131               HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 132               HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)

TABLE 133               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 134               EUROPE: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 135               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 136               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 137               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 138               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 139               HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2023–2030 (USD MILLION)

TABLE 140               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 141               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 142               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 143               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 144               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 145               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 146               HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION)

TABLE 147               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 148               EUROPE: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 149               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 150               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 151               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 152               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 153               HIGH-CONTENT SCREENING MARKET, BY REGION, 2023–2030 (USD MILLION)

TABLE 154               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 155               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 156               NORTH AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 157               NORTH AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 158               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 159               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 160               NORTH AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 161               US: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 162               US: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 163               US: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 164               US: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 165               US: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 166               US: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 167               CANADA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 168               CANADA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 169               CANADA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 170               CANADA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 171               CANADA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 172               CANADA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 173              EUROPE: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 174               EUROPE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 175               EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 176               EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 177               EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 178               EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 179               EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 180               EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 181               GERMANY: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 182               GERMANY: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 183               GERMANY: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 184               GERMANY: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 185               GERMANY: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 186               UK: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 187               UK: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 188               UK: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 189               UK: HIGH-CONTENT SCREENING MARKET, BY application, 2023–2030 (USD MILLION)

TABLE 190               UK: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 191               UK: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 192               FRANCE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 193               FRANCE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 194               FRANCE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 195               FRANCE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION

TABLE 196               FRANCE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 197               FRANCE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 198               ITALY: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 199               ITALY: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 200               ITALY: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 201               ITALY: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 202               ITALY: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 203               ITALY: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 204               SPAIN: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 205               SPAIN: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 206               SPAIN: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 207               SPAIN: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 208               SPAIN: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 209               SPAIN: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION

TABLE 210               REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 211               REST OF EUROPE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 212               REST OF EUROPE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 213               REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 214               REST OF EUROPE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 215               REST OF EUROPE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 216               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 217               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 218               ASIA PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 219               ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 220               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 221               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 222               ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 223               CHINA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 224               CHINA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 225               CHINA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 226               CHINA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 227               CHINA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 228               CHINA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 229               JAPAN: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 230               JAPAN: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 231               JAPAN: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 232               JAPAN: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 233               JAPAN: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 234               JAPAN: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 235               INDIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 236               INDIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 237               INDIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 238               INDIA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 239               INDIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 240               INDIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 241               SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 242               SOUTH KOREA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION

TABLE 243               SOUTH KOREA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 244               SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 245               SOUTH KOREA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 246               SOUTH KOREA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 247               AUSTRALIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 248               AUSTRALIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 249               AUSTRALIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 250               AUSTRALIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 251               AUSTRALIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 252               AUSTRALIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 253               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 254               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 255               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 256               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 257               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 258               REST OF ASIA PACIFIC: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 259               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 260               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 261               LATIN AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 262               LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 263               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 264               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 265               LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 266               BRAZIL: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 267              BRAZIL: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 268               BRAZIL: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 269               BRAZIL: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 270               BRAZIL: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 271               BRAZIL: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 272               MEXICO: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 273               MEXICO: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 274               MEXICO: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 275               MEXICO: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 276               MEXICO: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 277              MEXICO: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 278               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 279               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 280               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 281               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 282               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 283               REST OF LATIN AMERICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 284               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 285               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 286               MIDDLE EAST: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 287               MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 288               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 289               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 290               MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 291               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)

TABLE 292               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 293               GCC COUNTRIES: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 294               GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 295               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 296               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 297               GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 298               SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 299               SAUDI ARABIA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 300               SAUDI ARABIA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION

TABLE 301               SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 302               SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 303               SAUDI ARABIA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 304               UAE: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 305               UAE: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 306               UAE: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 307               UAE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 308               UAE: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 309               UAE: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 310               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 311               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 312               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 313               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 314               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 315               REST OF GCC COUNTRIES: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 316              REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 317               REST OF MIDDLE EAST: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 318               REST OF MIDDLE EAST: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 319              REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 320               REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 321              REST OF MIDDLE EAST: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 322               AFRICA: HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)

TABLE 323              AFRICA: HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 324               AFRICA: HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)

TABLE 325               AFRICA: HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)

TABLE 326               AFRICA: HIGH-CONTENT SCREENING MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)

TABLE 327               AFRICA: HIGH-CONTENT SCREENING MARKET, BY END USER, 2023–2030 (USD MILLION)

TABLE 328               DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 329               DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–FEBRUARY 2025

TABLE 330               REVVITY: PRODUCTS/SERVICES OFFERED

TABLE 331               REVVITY: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–FEBRUARY 2025

TABLE 332               BD: PRODUCTS /SERVICES OFFERED

TABLE 333               BD: DEALS, JANUARY 2022–FEBRUARY 2025

TABLE 334               THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED

TABLE 335               AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED

TABLE 336               MERCK KGAA: PRODUCTS/SERVICES OFFERED

TABLE 337               BIO-RAD LABORATORIES: PRODUCTS/SERVICES OFFERED

TABLE 338               BIO-RAD LABORATORIES: DEALS, JANUARY 2022–FEBRUARY 2025

TABLE 339               NIKON CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 340               NIKON CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–FEBRUARY 2025

TABLE 341               NIKON CORPORATION: EXPANSIONS, JANUARY 2022–FEBRUARY 2025

TABLE 342               CARL ZEISS AG: PRODUCTS/SERVICES OFFERED

TABLE 343               CARL ZEISS AG: DEALS, JANUARY 2022–FEBRUARY 2025

TABLE 344               SARTORIUS AG: PRODUCTS/SERVICES OFFERED

TABLE 345               SARTORIUS AG: DEALS, JANUARY 2022–FEBRUARY 2025

TABLE 346               YOKOGAWA ELECTRIC CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 347               YOKOGAWA ELECTRIC CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2022–FEBRUARY 2025

TABLE 348               TECAN: PRODUCTS/SERVICES OFFERED

TABLE 349               CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED

TABLE 350               CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED

TABLE 351               EVIDENT: PRODUCTS/SERVICES OFFERED

TABLE 352               PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 353               CREATIVE BIOLABS: PRODUCTS/SERVICES OFFERED

TABLE 354               SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 355               ENZO LIFE SCIENCES: PRODUCTS /SERVICES OFFERED

TABLE 356               STRATEDIGM: PRODUCTS/SERVICES OFFERED

TABLE 357               AKOYA BIOSCIENCES: PRODUCTS/SERVICES OFFERED

TABLE 358               SPHERE FLUIDICS: PRODUCTS/SERVICES OFFERED

TABLE 359               CREATIVE BIOSTRUCTURE: PRODUCTS/SERVICES OFFERED

TABLE 360               CREATIVE BIOARRAY: PRODUCTS/SERVICES OFFERED

TABLE 361               CELL SIGNALING TECHNOLOGY: PRODUCTS/SERVICES OFFERED

TABLE 362               STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED

TABLE 363               ARACELI BIOSCIENCES: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES:

FIGURE 1 HIGH-CONTENT SCREENING MARKET SEGMENTATION AND REGIONAL SCOPE

FIGURE 2 HIGH-CONTENT SCREENING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS

FIGURE 3 HIGH-CONTENT SCREENING MARKET SIZE ESTIMATION, 2024

FIGURE 4 APPROACH 1: COMPANY REVENUE ANALYSIS-BASED MARKET ESTIMATION, 2024

FIGURE 5 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2024)

FIGURE 6 SEGMENTAL SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH (2024)

FIGURE 7 HIGH-CONTENT SCREENING MARKET: CAGR PROJECTIONS

FIGURE 8 HIGH-CONTENT SCREENING MARKET: CAGR PROJECTIONS

FIGURE 9 HIGH-CONTENT SCREENING MARKET, BY PRODUCT & SERVICE, 2025–2030

FIGURE 10               HIGH-CONTENT SCREENING INSTRUMENTS MARKET, BY TYPE,

2025–2030

FIGURE 11               HIGH-CONTENT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2025–2030

FIGURE 12               HIGH-CONTENT SCREENING MARKET, BY APPLICATION, 2025–2030

FIGURE 13               HIGH-CONTENT SCREENING MARKET, BY END USER, 2025–2030

FIGURE 14               HIGH-CONTENT SCREENING MARKET: GEOGRAPHIC ANALYSIS

FIGURE 15               TECHNOLOGICAL ADVANCEMENTS IN HIGH-CONTENT SCREENING INSTRUMENTS TO DRIVE MARKET GROWTH

FIGURE 16               INSTRUMENTS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2024

FIGURE 17               CHINA LIKELY TO REGISTER HIGHEST GROWTH IN GLOBAL HIGH-CONTENT SCREENING MARKET OVER FORECAST PERIOD

FIGURE 18               HIGH-CONTENT SCREENING MARKET, BY END USER, 2024

FIGURE 19               AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY KEY PLAYER, 2022–2024

FIGURE 20               AVERAGE SELLING PRICE TREND OF HIGH-CONTENT SCREENING PRODUCTS, BY REGION, 2022–2024

FIGURE 21               HIGH-CONTENT SCREENING MARKET: VALUE CHAIN ANALYSIS

FIGURE 22               HIGH-CONTENT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 23               KEY BUYING CRITERIA FOR HCS PRODUCTS, BY END USER

FIGURE 24               HIGH-CONTENT SCREENING MARKET: ECOSYSTEM ANALYSIS

FIGURE 25               IMPACT OF AI ON HIGH-CONTENT SCREENING ECOSYSTEM

FIGURE 26               HIGH-CONTENT SCREENING MARKET: INVESTMENT & FUNDING SCENARIO

FIGURE 27               HIGH-CONTENT SCREENING MARKET: PATENT ANALYSIS, 2014−2024

FIGURE 28               REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN HIGH-CONTENT SCREENING MARKET, 2020–2024

FIGURE 29               HIGH-CONTENT SCREENING MARKET SHARE ANALYSIS, 2024

FIGURE 30               EV/EBIDTA OF KEY VENDORS, 2025

FIGURE 31               YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• コンクリートシーラー市場 – 2030年までの世界予測 2025-04-21
• 自動車用ヒートシールド市場 – 2032年までの世界予測 2025-04-21
• XEVアフターマーケットの進化に関する競争力情報 – 2035年までの世界予測 2025-04-17
• アプリケーションライフサイクル管理市場 – 2029年までの世界予測 2025-04-17
• ヒンダードアミン光安定剤（HALS）市場 – 2030年までの世界予測 2025-04-17

MarketsandMarkets  出版レポート一覧